Pacira Pharmaceuticals buy HC Wainwright
Start price
06.11.23
/
50%
€28.40
Target price
06.11.24
€53.07
Performance (%)
-47.89%
Price
03.10.24
€14.10
Summary
This prediction is currently active. Massive losses of -47.89% have been the result for the BUY prediction by HC_Wainwright. This prediction currently runs until 06.11.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Pacira Pharmaceuticals | 10.400% | 10.400% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its price target lowered by analysts at HC Wainwright from $63.00 to $57.00. They now have a "buy" rating on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€21.20
02.07.24
02.07.24
€53.05
02.07.25
02.07.25
-30.19%
03.10.24
03.10.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€53.04
08.05.25
08.05.25
-44.78%
03.10.24
03.10.24
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
04.03.24
04.03.24
€52.53
04.03.25
04.03.25
-46.56%
03.10.24
03.10.24